Market Newsdesk

March 26, 2021 9:55 pm

Armanino Foods of Distinction, Inc. Increases Its Regular Quarterly Dividend by Approximately 29% to $0.0225 Per Share

HAYWARD, Calif.–(BUSINESS WIRE)–
Armanino Foods of Distinction, Inc. (OTC Pink: AMNF) today announced that its board of directors has declared a regular quarterly cash dividend of $0.0225 per share representing an increase of approximately 29% from its most recent three quarterly dividends. The dividend will be payable to shareholders of record on April 6, 2021 and will be disbursed on or about April 28, 2021. This is the Company’s 83^rd consecutive quarterly dividend. In addition, the Company has had ten special dividends.

Douglas R. Nichols, Chairman of the board stated, “The strength and resilience of our Company continues to be proven as we emerge from the ongoing macroeconomic situation. As a result, we are pleased to announce that we are increasing our dividend by 29% versus the previous three quarters. Despite the obstacles presented by the COVID-19 pandemic, the Company has been able to successfully weather this storm. By implementing tactics which have kept the Company profitable, the Company has paid down its debt ahead of schedule and grown its cash position. However, rather than returning to our pre-pandemic dividend rate of $0.0275 per share, we will continue to pay down our line of credit with the $160,000 in savings from the dividend reduction just as we have done in the past three quarters.”

Tim Anderson, President and CEO commented, “We are pleased to start 2021 with anticipated quarter over quarter sales and profit growth. We are on track with our plans to position the Company for recovery from the impact of COVID-19, while also continuing to strategically invest in diversified channels to capitalize on growth trends as demonstrated by our growth in sales and profits in the past three consecutive quarters. This growth was largely attributable to our ability to control our costs and expenses throughout our organization. Specifically, this included focused efforts to control our promotional and G&A spending. Furthermore, investments in technology to improve manufacturing efficiencies continue to reduce our relative production costs. We also continued to benefit from various cost cutting measures put in place since the beginning of the COVID-19 pandemic.”

Anderson continued, “The effects of the second surge of COVID-19 cases are easing with fewer weekly infections, lifting of state and local government restrictions and warmer weather. These conditions are resulting in an improvement in overall sales, but particularly to our Foodservice customers. We have also found that our customers are building their inventories in anticipation of future sales. We will continue to make investments to reposition the Company for recovery from the current economic environment for sustained future growth with an eye towards new products, new markets, and potential acquisitions. Given our financial resources, the strength of our brand, and proven track record of management excellence, we remain confident in our ability to achieve our long‐term vision for the Company despite the current economic environment.”

Armanino Foods of Distinction, Inc. is an international food company that manufactures, and markets frozen Italian specialty food items such as pestos, sauces and filled pastas to the foodservice, retail, and industrial markets. In addition to a classic Basil Pesto Armanino offers other flavors such as Cilantro, Dried Tomato & Garlic, Roasted Red Bell Pepper, Southwest Chipotle, Artichoke, Roasted Garlic, Light Basil Pesto, Chimichurri, Harissa, Bolognese, Alfredo sauce, Creamy Garlic, and Romesco. Armanino’s organic line includes classic Basil Pesto. Armanino Foods also offers cheese shakers, frozen pastas, and meatballs.

The best source of information on the company is the OTC Markets website (http://www.otcmarkets.com/stock/AMNF/company-info).

View source version on businesswire.com: https://www.businesswire.com/news/home/20210326005501/en/

Edgar Estonina

COO/CFO

(510) 441-9300

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Supermarket Retail Restaurant/Bar Food/Beverage

MEDIA:

Logo

March 26, 2021 9:19 pm

UPDATE: LMH Sets Ambitious Target to Reach 110,000+ Training Hours Enterprise-wide in 2021

New Initiatives Provides Team Members 150+ Hours of Annual Training Hours

San Diego, CA, March 26, 2021 (GLOBE NEWSWIRE) — This is an update on the announcement. The correction: LMH Sets Ambitious Target to Reach 110,000+ Training Hours

LMH’s CEO/COO Philip Rizzo recently announced the launch of a new innovative program to bolster its workforce’s training and development. LMH, a leading provider of military housing, has set an ambitious goal to achieve 150+ hours of annual training for each team member and over 110,000 hours as an organization.

The new program called EmpHour provides uninterrupted scheduled time dedicated to training and professional development, enhancing every team member’s skills and knowledge across the organization. The extensive training program will most importantly ensure a consistent, efficient, quality experience for all 36,000 families living with LMH.

Part of the company’s mission is to provide team members with unparalleled opportunities for professional growth and development, and LMH designed its latest training initiative with that goal in mind. EmpHour provides team members time to embrace educational opportunities that facilitate learning and growth as professionals.

Through the implementation of this program, there has also been a heavy emphasis on training development, which focuses on topics ranging from best workplace practices to workplace culture and modules that offer insight into serving military families best.

EmpHour is a training initiative unique to any of the training programs currently implemented in the multifamily or military housing landscape. The Association for Talent Development reported in 2020 that larger companies have been “increasing their investment in staff training over the last few years” and that the average number of training hours provided annually has increased to 34.7 hours per employee.

This year marks the 20^th anniversary of LMH providing exemplary service to military families. CEO/COO Philip Rizzo recently asked all team members to rededicate their daily efforts to meet that mission. “Research reflects that average mid-sized companies provide just 34.7 hours of training annually. The EmpHour initiative helps our teams increase that number fivefold. In turn, this will help us fulfill our mission to our military families, partners, and our teams,” said Rizzo.

With the first quarter not yet over, LMH team members have already completed 50,000+ hours of training. EmpHour serves as that commitment to team members and allows each person to set time for professional development. Training is instrumental in creating a dynamic and well-rounded team. As technology continues to advance and workplace methodology improves, team members need to align skills, knowledge, values, and abilities. EmpHour will help enhance learning with ongoing training that exposes team members to relevant courses, improving performance over time.

About Lincoln Military Housing

Lincoln Military Housing (LMH) was formed in 2001 through a Department of Defense (DOD) contract with parent company Lincoln Property Company. The goal has always been to increase military housing quality for our nation’s servicemen and women. Since its inception more than a decade ago, Lincoln Military Housing now provides more than 36,000 family homes for military members across the US. Lincoln is much more than a property management company. LMH acts as a support system for military families and offers community-building activities and 24-hour maintenance assistance programs, free to all residents. Services are available for all branches of service — Marine Corps, Army, Navy, Air Force, United States Coast Guard, and National Guard. For more information about Lincoln Military Housing, please visit www.lincolnmilitary.com for more details.

Brooke Scarbrough
Lincoln Military Housing
757.618.6825
[email protected]

March 26, 2021 9:03 pm

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Ascendant Digital Acquisition Corp. – ACND

PR Newswire

NEW YORK, March 26, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Ascendant Digital Acquisition Corp. (“ACND” or the “Company”) (ACND) relating to its proposed merger with Beacon Street Group. Under the terms of the agreement, ACND shareholders will own only 13% of the combined company.

The investigation focuses on whether Ascendant Digital Acquisition Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, 2) whether the transaction is properly valued, and 3) whether all material information has been disclosed.

Click here for more information: https://www.monteverdelaw.com/case/ascendant-digital-acquisition-corp
.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in Ascendant Digital Acquisition Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2021 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-ascendant-digital-acquisition-corp–acnd-301257014.html

SOURCE Monteverde & Associates PC

March 26, 2021 9:03 pm

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of NavSight Holdings, Inc. – NSH

PR Newswire

NEW YORK, March 26, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating NavSight Holdings, Inc. (“NSH” or the “Company”) (NSH) relating to its proposed merger with Spire Global. Under the terms of the agreement, NSH shareholders will own only 14% of the combined company.

The investigation focuses on whether NavSight Holdings, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

Click here for more information: https://www.monteverdelaw.com/case/navsight-holdings-inc
.
It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

If you own common stock in NavSight Holdings, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

SOURCE Monteverde & Associates PC

March 26, 2021 9:03 pm

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against AstraZeneca PLC and Encourages Investors to Contact the Firm

NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased AstraZeneca PLC (NASDAQ: AZN) American Depository Shares (“ADSs”) between May 21, 2020 and November 20, 2020 (the “Class Period”). Investors have until March 29, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

AstraZeneca is one of the largest biopharmaceutical companies in the world and was one of the early front-runners in the race to develop a COVID-19 vaccine. In April 2020, the Company partnered with Oxford University to develop a potential recombinant adenovirus vaccine for the virus, later dubbed AZD1222.

On November 23, 2020, AstraZeneca issued a release announcing the results of an interim analysis of its ongoing trial for AZD1222. The announcement immediately began to raise questions among analysts and industry experts. AstraZeneca disclosed that the interim analysis involved two smaller scale trials in disparate locales (the United Kingdom and Brazil) that, for unexplained reasons, employed two different dosing regimens. One clinical trial provided patients a half dose of AZD1222 followed by a full dose, while the other trial provided two full doses. Counterintuitively, AstraZeneca claimed that the half dosing regimen was substantially more effective at preventing COVID-19 at 90% efficacy than the full dosing regimen, which had achieved just 62% efficacy.

In the days that followed, additional revelations were made regarding problems with AstraZeneca’s AZD1222 clinical trials. For example, the differing dosing regimens were revealed to be due to a manufacturing error rather than trial design. Also, the half-strength dose had not been tested in people over the age of 55 – despite the fact that this population was the most vulnerable to COVID-19. Moreover, certain trial participants received their second dose later than originally planned. U.S. regulators stated that if AstraZeneca could not clearly explain the discrepancies in its trial results, the results would most likely not be sufficient for approval for commercial sale in the United States.

As negative news reports continued to reveal previously undisclosed problems and flaws in AstraZeneca’s clinical trials for AZD1222, the price of AstraZeneca ADSs fell to $52.60 by market close on November 25, 2020, a 5% decline over three trading days in response to adverse news.

The complaint, filed on July 26, 2021, alleges that defendants misrepresented facts regarding the Company’s ongoing AZD1222 clinical trials and concealed problems that had arisen in the trials, including a dosing error which had been discovered early on by the Company but not disclosed to investors.

If you purchased AstraZeneca ADSs during the Class Period and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com

March 26, 2021 9:00 pm

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages MoneyGram International, Inc. Investors to Secure Counsel Before Important April 30 Deadline – MGI

PR Newswire

NEW YORK, March 26, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of MoneyGram International, Inc. (NASDAQ: MGI) between June 17, 2019 and February 22, 2021, inclusive (the “Class Period”), of the important April 30, 2021 lead plaintiff deadline.

SO WHAT: If you purchased MoneyGram securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the MoneyGram class action, go to http://www.rosenlegal.com/cases-register-2046.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 30, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) XRP, the cryptocurrency that MoneyGram was utilizing as part of its Ripple partnership, was viewed as an unregistered and therefore unlawful security by the SEC; (2) in the event that the SEC decided to enforce the securities laws against Ripple, MoneyGram would be likely to lose the lucrative stream of market development fees that was critical to its financial results throughout the Class Period; and (3) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the MoneyGram class action, go to http://www.rosenlegal.com/cases-register-2046.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40^th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-global-investor-counsel-encourages-moneygram-international-inc-investors-to-secure-counsel-before-important-april-30-deadline–mgi-301257025.html

SOURCE Rosen Law Firm, P.A.

March 26, 2021 8:48 pm

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Root, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – ROOT

PR Newswire

NEW YORK, March 26, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Root, Inc. (NASDAQ: ROOT) who: (1) purchased or otherwise acquired publicly traded Root securities between October 28, 2020 and March 8, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Root Class A common stock pursuant and/or traceable to the Offering documents issued in connection with the Company’s initial public offering conducted on or about October 28, 2020 (the “IPO” or “Offering”). If you wish to serve as lead plaintiff, you must move the Court no later than May 18, 2021.

SO WHAT: If you purchased Root securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Root class action, go to http://www.rosenlegal.com/cases-register-2061.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. If you wish to serve as lead plaintiff, you must move the Court no later than May 18, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: According to the lawsuit, the Offering documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (2) accordingly, the Company would foreseeably require significant cash infusions to meet its cash flow needs; (3) notwithstanding the defendants’ touting of Root’s purportedly unique, data-driven advantages, several of the Company’s established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (4) as a result, the Offering documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Root class action, go to http://www.rosenlegal.com/cases-register-2061.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-top-ranked-investor-counsel-encourages-root-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before-important-deadline–root-301257026.html

SOURCE Rosen Law Firm, P.A.

March 26, 2021 8:38 pm

ROSEN, LEADING INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CYDY

PR Newswire

NEW YORK, March 26, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CytoDyn Inc. (OTC: CYDY) between March 27, 2020 and March 9, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021.

SO WHAT: If you purchased CytoDyn securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the CytoDyn class action, go to http://www.rosenlegal.com/cases-register-2060.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements touting Leronlimab as a potential treatment for COVID-19 to pump up the CytoDyn’s stock price while executives aggressively sold their shares. The complaint also alleges that CytoDyn engaged in a wrongful scheme whereby Iliad Research and Trading L.P. and other entities related to Iliad’s principal John Fife operated as an unregistered securities dealer for CytoDyn. On this news, the Company’s share price fell $1.14 per share, or 28%, to close at $2.91 on March 8, 2021. On March 9, 2021, CytoDyn shares dropped an additional 19% to close at $2.35, thereby injuring investors further.

To join the CytoDyn class action, go to http://www.rosenlegal.com/cases-register-2060.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-leading-investor-counsel-encourages-cytodyn-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before-important-deadline–cydy-301257027.html

SOURCE Rosen Law Firm, P.A.

March 26, 2021 8:36 pm

Dave & Buster’s Announces Expiration of Shareholder Rights Plan

DALLAS, March 26, 2021 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ: PLAY), (“Dave & Buster’s” or the “Company”), an owner and operator of entertainment and dining venues, today announced that its shareholder rights plan, originally adopted in March 2020, has expired in accordance with its terms on March 17, 2021. Shareholders are not required to take any action as a result of this expiration.

In connection with the expiration of the shareholder rights plan, the Company will take routine steps to voluntarily de-register the related preferred stock purchase rights under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has not arranged for listing or registration on another national securities exchange or quotation for the preferred stock purchase rights, because such rights have terminated. These actions are administrative in nature and will have no effect on the Company’s common stock, which continues to be listed on the NASDAQ Global Select Market and registered under the Exchange Act.

About Dave & Buster’s Entertainment, Inc.

Founded in 1982 and headquartered in Dallas, Texas, Dave & Buster’s Entertainment, Inc., is the owner and operator of 141 venues in North America that combine entertainment and dining and offer customers the opportunity to “Eat Drink Play and Watch,” all in one location. Dave & Buster’s offers a full menu of entrées and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. Dave & Buster’s currently has stores in 40 states, Puerto Rico, and Canada.

Forward-Looking Statements

The Company cautions that this release contains forward-looking statements, including, without limitation, statements relating to the impact on our business and operations of the global spread of the novel coronavirus outbreak. These forward-looking statements involve risks and uncertainties and, consequently, could be affected by the uncertain and unprecedented impact of the coronavirus on our business and operations and the related impact on our liquidity needs; our ability to satisfy covenant requirements under our revolving credit facility; the duration of government-mandated and voluntary shutdowns; the speed with which our stores safely can be reopened and the level of customer demand following reopening; the economic impact of the coronavirus and related disruptions on the communities we serve; our overall level of indebtedness; general business and economic conditions, including as a result of the coronavirus; the impact of competition; the seasonality of the Company’s business; adverse weather conditions; future commodity prices; guest and employee complaints and litigation; fuel and utility costs; labor costs and availability; changes in consumer and corporate spending, including as a result of the coronavirus; changes in demographic trends; changes in governmental regulations; unfavorable publicity, our ability to open new stores, and acts of God. Accordingly, actual results may differ materially from the forward-looking statements, and the Company therefore cautions you against relying on such forward-looking statements. Dave & Buster’s intends these forward-looking statements to speak only as of the time of this release and does not undertake to update or revise them as more appropriate information becomes available, except as required by law.

For Investor Relations Inquiries

Scott Bowman, CFO
Dave & Buster’s Entertainment, Inc.
972.813.1151
[email protected]

March 26, 2021 8:33 pm

NEPT INVESTOR ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Neptune Wellness Solutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – NEPT

PR Newswire

NEW YORK, March 26, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Neptune Wellness Solutions Inc. (NASDAQ: NEPT) between July 24, 2019 and February 16, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021.

SO WHAT: If you purchased Neptune securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Neptune class action, go to http://www.rosenlegal.com/cases-register-2059.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) the cost of Neptune’s integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than Neptune had acknowledged, placing significant strain on Neptune’s capital reserves; (2) accordingly, it was reasonably foreseeable that Neptune would need to conduct additional stock offerings to raise more capital; and (3) as a result, Neptune’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Neptune class action, go to http://www.rosenlegal.com/cases-register-2059.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

View original content to download multimedia:http://www.prnewswire.com/news-releases/nept-investor-alert-rosen-top-ranked-investor-counsel-encourages-neptune-wellness-solutions-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before-important-deadline–nept-301257024.html

SOURCE Rosen Law Firm, P.A.